Compared with the toxicity that we see
with allogeneic donor hematopoietic stem cell therapy, these toxicities are relatively manageable with close monitoring and close supportive care.
Not exact matches
The subindication for which now data were available for the first time was
allogeneic SCT
with related
donor in comparison
with allogeneic SCT
with unrelated
donor.
HSCT is effectively used today as a form of «replacement» therapy for patients
with hard - to - treat blood cancers, providing healthy cells from either the patient (autologous transplantation) or from a
donor (
allogeneic transplantation) to better equip patients to fight the disease on their own.
The only documented long - term complete remissions reported in multiple myeloma patients have occurred
with allogeneic bone marrow transplantation, where a
donor's blood stem cells (graft) are transplanted into the patient (host)
with multiple myeloma.
Allogeneic Sibling
Donor Peripheral Blood Stem Cells Transplantation
With Myeloablative Conditioning for Chronic Myeloid Leukemia in Blast Crisis - Successful Treatment Despite Severe Phase of the Disease
Horwitz et al 79 reported that
donor MSC contributed to bone remodelling after
allogeneic stem cell transplantation (SCT) in 3 children
with osteogenesis imperfecta, a rare genetic disorder of type I collagen.
In the future, outpatient blood and bone marrow stem cell transplantation will be offered to a broader group of patients
with other blood disorders and for
allogeneic transplants (transplant from non-twin
donor stem cells).
Use of a lower dose of rabbit anti — T - lymphocyte globulin (ATLG) was superior to a higher dose in children
with hematologic malignancies undergoing
allogeneic hematopoietic stem cell transplantation (HSCT) from an unrelated
donor, according to the results of a study published in Lancet Oncology.
Patients receive one of two types of stem cell - based transplants: autologous, in which a patient donates and receives back his / her own stem cells; or
allogeneic, in which bone marrow - derived stem cells come from a related or unrelated
donor whose human leukocyte antigens (HLA) are genetically matched
with those of a patient.
Low - Dose ATLG Prevents GVHD in Pediatric Hematologic Malignancies: A newly published randomized phase III study of pediatric patients showed lower doses of rabbit anti — T - lymphocyte globulin (ATLG) was superior to a higher dose in children
with hematologic malignancies undergoing
allogeneic hematopoietic stem cell transplantation from an unrelated
donor.
Allogeneic cell therapies from primary cells for immunotherapy applications are especially challenging because of the vigor
with which tissue
donors must be screened and qualified to prevent transmission of infectious disease and ensure maintenance of an active
donor pool.